1. Home
  2. EMBC vs AVDL Comparison

EMBC vs AVDL Comparison

Compare EMBC & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • AVDL
  • Stock Information
  • Founded
  • EMBC 1924
  • AVDL 2015
  • Country
  • EMBC United States
  • AVDL Ireland
  • Employees
  • EMBC N/A
  • AVDL N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • EMBC Health Care
  • AVDL Health Care
  • Exchange
  • EMBC Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • EMBC 716.2M
  • AVDL 784.6M
  • IPO Year
  • EMBC N/A
  • AVDL 1996
  • Fundamental
  • Price
  • EMBC $11.97
  • AVDL $9.39
  • Analyst Decision
  • EMBC Hold
  • AVDL Strong Buy
  • Analyst Count
  • EMBC 3
  • AVDL 7
  • Target Price
  • EMBC $17.67
  • AVDL $18.86
  • AVG Volume (30 Days)
  • EMBC 445.0K
  • AVDL 1.2M
  • Earning Date
  • EMBC 05-09-2025
  • AVDL 05-07-2025
  • Dividend Yield
  • EMBC 5.02%
  • AVDL N/A
  • EPS Growth
  • EMBC N/A
  • AVDL N/A
  • EPS
  • EMBC 0.89
  • AVDL N/A
  • Revenue
  • EMBC $1,079,500,000.00
  • AVDL $194,450,000.00
  • Revenue This Year
  • EMBC N/A
  • AVDL $50.53
  • Revenue Next Year
  • EMBC $0.99
  • AVDL $32.33
  • P/E Ratio
  • EMBC $13.36
  • AVDL N/A
  • Revenue Growth
  • EMBC N/A
  • AVDL 252.64
  • 52 Week Low
  • EMBC $10.12
  • AVDL $6.38
  • 52 Week High
  • EMBC $21.48
  • AVDL $17.85
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 46.46
  • AVDL 64.66
  • Support Level
  • EMBC $12.08
  • AVDL $8.55
  • Resistance Level
  • EMBC $13.45
  • AVDL $9.98
  • Average True Range (ATR)
  • EMBC 0.59
  • AVDL 0.51
  • MACD
  • EMBC 0.13
  • AVDL 0.10
  • Stochastic Oscillator
  • EMBC 40.75
  • AVDL 72.04

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: